H.C. Wainwright Starts Evaxion Biotech (EVAX) at Buy, 'An Underappreciated AI-Immunology Company With Validated Tools'

February 12, 2024 6:26 AM EST Send to a Friend
(Updated - February 12, 2024 8:14 AM EST)

H.C. Wainwright analyst Swayampakula Ramakanth initiates coverage on Evaxion Biotech (NASDAQ ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login